Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Talphera will host a fireside chat and 1x1 investor meetings at the H.C. Wainwright conference, with live webcast and 90-day replay access.

Rhea-AI Summary

Talphera (TLPH)/b) will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026, at 4:30 p.m. ET in New York, NY.The session will feature a fireside chat and 1x1 meetings with CEO Vince Angotti and Chief Medical Officer Shakil Aslam, MD. A webcast and 90-day replay will be available via Talphera’s investor website.

Market Context

Before this announcement, TLPH had a 1.69% pre-headline gain, while the release disclosed only confe...

Analysis

Before this announcement, TLPH had a 1.69% pre-headline gain, while the release disclosed only conference participation details. The active S-3 is a resale registration; investors can watch for subsequent operating or financing disclosures.

Key Figures

Conference Edition: 28th annual Presentation Date: September 14, 2026 at 4:30pm ET Meeting Format: 1x1 meetings +1 more

4 metrics

Conference Edition 28th annual H.C. Wainwright Global Investment Conference

Presentation Date September 14, 2026 at 4:30pm ET H.C. Wainwright conference

Meeting Format 1x1 meetings Alongside fireside chat

Webcast Replay 90 days Following the event

Historical Context

5 past events · Latest: Aug 12 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 12	Second-quarter earnings	Positive	-13.6%	Clinical enrollment progress and guideline support accompanied quarterly financial results.
Aug 05	Earnings-date announcement	Neutral	+5.9%	Company scheduled its second-quarter results conference call and webcast.
May 13	First-quarter earnings	Positive	-0.4%	Trial enrollment progress and a $4.1 million financing tranche were reported.
May 07	Earnings-date announcement	Neutral	+2.9%	Company announced the release date for first-quarter financial results.
Mar 25	Abstract presentation acceptance	Positive	+9.1%	Two abstracts covering nafamostat and the NEPHRO-CRRT trial were accepted.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Historical reactions were mixed: the March 25 abstracts announcement aligned positively, while later earnings-related updates diverged from their stated news sentiment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN MATEO, Calif., Sept. 3, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that Company management will be presenting at the H.C. Wainwright 28th Annual Global Investment Conference.

H.C. Wainwright 28th Annual Global Investment Conference
Date: Monday, September 14, 2026 at 4:30pm ET
Location: New York, NY
Presenter: Chief Executive Officer, Vince Angotti, and Chief Medical Officer, Shakil Aslam, MD
Format: Fireside Chat and 1x1 Meetings

Webcast Information

The webcast can be accessed here or by visiting the Talphera website on the News & Events section of the Investors page. A replay of the webcast will be available for 90 days following the event.

About Talphera, Inc.

Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad® is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA).

This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-participate-in-the-hc-wainwright-28th-annual-global-investment-conference-302868347.html

SOURCE Talphera, Inc.

FAQ

When will Talphera (TLPH) present at the H.C. Wainwright 28th Annual Global Investment Conference?

Talphera is scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026 at 4:30 p.m. ET in New York, NY.

Who will present for Talphera (TLPH) at the H.C. Wainwright 2026 conference?

Talphera’s presenters at the H.C. Wainwright 28th Annual Global Investment Conference will be Chief Executive Officer Vince Angotti and Chief Medical Officer Shakil Aslam, MD.

What is the format of Talphera’s (TLPH) appearance at the H.C. Wainwright 28th Annual Global Investment Conference?

Talphera’s participation will include a fireside chat and 1x1 meetings with investors as part of the H.C. Wainwright 28th Annual Global Investment Conference.

How can investors access the Talphera (TLPH) webcast from the H.C. Wainwright conference?

The webcast of Talphera’s conference appearance can be accessed via a provided link or by visiting the News & Events section of the Investors page on the Talphera website.

How long will the replay of Talphera’s (TLPH) H.C. Wainwright conference webcast be available?

A replay of Talphera’s webcast from the H.C. Wainwright 28th Annual Global Investment Conference will be available for 90 days following the event.